Stay updated with breaking news from Verve Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Swiss start-up Limula has raised $6.8 million of funding to help it towards commercialising a machine that could help an incredible new treatment reach many more patients
The corporate VC fund has already backed 25 AI and data startups.
Life science startup Limula has raised $6.8 million to take its solution for automating cell therapy manufacturing to the next stage of development.
Switzerland-based Limula has raised $6.8mn to further develop its technology that aims to automate cell therapy manufacturing.
Investegate announcements from Investment in Memo Therapeutics